Stabilization of Self-Pressurized Gelatin Capsules for Oral Delivery of Biologics.

IF 5.5 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Amy J Wood-Yang, Joshua I Palacios, Abishek Sankaranarayanan, Mark R Prausnitz
{"title":"Stabilization of Self-Pressurized Gelatin Capsules for Oral Delivery of Biologics.","authors":"Amy J Wood-Yang, Joshua I Palacios, Abishek Sankaranarayanan, Mark R Prausnitz","doi":"10.3390/pharmaceutics17091156","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives:</b> Oral delivery of biologics offers advantages for patient access and adherence compared to injection, but suffers from low bioavailability due to mucosal barriers and drug degradation in the gastrointestinal tract. We previously developed an oral self-pressurized aerosol (OSPRAE) capsule that uses effervescent excipients to generate CO<sub>2</sub> gas, building internal pressure to eject powdered drug at high velocity across intestinal mucosa. <b>Methods:</b> Here, we developed two key design improvements: (i) an enteric covering to protect the capsule delivery orifice in gastric fluids and (ii) reduced humidity content of capsules to extend shelf-life. <b>Results:</b> Enteric-covered capsules prevented drug release in simulated gastric fluid and then enabled rapid release upon transfer to simulated intestinal fluid. Burst pressure for enteric-covered capsules was ~3-4 times higher than non-covered capsules. After storage for up to three days, the capsules' effervescent excipients pre-reacted, making them unable to achieve high pressure during subsequent use. To address this limitation, we prepared capsules under reduced humidity conditions, which inhibited pre-reaction of effervescent excipients during storage, and a polyurethane coating to improve water uptake into the capsule to drive the effervescence reaction in intestinal fluid. <b>Conclusions:</b> These design improvements enable improved functionality of OSPRAE capsules for continued translation in pre-clinical and future clinical development.</p>","PeriodicalId":19894,"journal":{"name":"Pharmaceutics","volume":"17 9","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12472849/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/pharmaceutics17091156","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: Oral delivery of biologics offers advantages for patient access and adherence compared to injection, but suffers from low bioavailability due to mucosal barriers and drug degradation in the gastrointestinal tract. We previously developed an oral self-pressurized aerosol (OSPRAE) capsule that uses effervescent excipients to generate CO2 gas, building internal pressure to eject powdered drug at high velocity across intestinal mucosa. Methods: Here, we developed two key design improvements: (i) an enteric covering to protect the capsule delivery orifice in gastric fluids and (ii) reduced humidity content of capsules to extend shelf-life. Results: Enteric-covered capsules prevented drug release in simulated gastric fluid and then enabled rapid release upon transfer to simulated intestinal fluid. Burst pressure for enteric-covered capsules was ~3-4 times higher than non-covered capsules. After storage for up to three days, the capsules' effervescent excipients pre-reacted, making them unable to achieve high pressure during subsequent use. To address this limitation, we prepared capsules under reduced humidity conditions, which inhibited pre-reaction of effervescent excipients during storage, and a polyurethane coating to improve water uptake into the capsule to drive the effervescence reaction in intestinal fluid. Conclusions: These design improvements enable improved functionality of OSPRAE capsules for continued translation in pre-clinical and future clinical development.

Abstract Image

Abstract Image

Abstract Image

口服生物制剂用自加压明胶胶囊的稳定性研究。
背景/目的:与注射相比,口服生物制剂在患者获取和依从性方面具有优势,但由于粘膜屏障和药物在胃肠道中的降解,生物利用度较低。我们之前开发了一种口服自加压气雾剂(OSPRAE)胶囊,它利用泡腾型辅料产生二氧化碳气体,建立内部压力,以高速将粉状药物喷射出肠粘膜。方法:在这里,我们开发了两个关键的设计改进:(i)肠覆盖层以保护胶囊在胃液中的输送口;(ii)降低胶囊的湿度含量以延长保质期。结果:肠覆盖胶囊阻止药物在模拟胃液中释放,并在转移到模拟肠液后快速释放。肠包膜胶囊的破裂压力比未包膜胶囊高3 ~ 4倍。在储存长达三天之后,胶囊的起泡赋形剂发生了预反应,使得它们在随后的使用中无法达到高压。为了解决这一限制,我们在低湿度条件下制备胶囊,以抑制储存过程中起泡辅料的预反应,并在聚氨酯涂层下制备胶囊,以提高胶囊的吸水率,从而推动肠液中的起泡反应。结论:这些设计改进使OSPRAE胶囊的功能得到改善,从而在临床前和未来的临床开发中继续转化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutics
Pharmaceutics Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.90
自引率
11.10%
发文量
2379
审稿时长
16.41 days
期刊介绍: Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications,  and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信